vs

Side-by-side financial comparison of Legacy Housing Corp (LEGH) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

Legacy Housing Corp is the larger business by last-quarter revenue ($25.5M vs $17.6M, roughly 1.4× AVITA Medical, Inc.). Legacy Housing Corp runs the higher net margin — 32.2% vs -66.0%, a 98.1% gap on every dollar of revenue. On growth, AVITA Medical, Inc. posted the faster year-over-year revenue change (-4.3% vs -30.6%). Legacy Housing Corp produced more free cash flow last quarter ($15.7M vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs -9.1%).

Legacy Housing Corp is a prominent U.S.-based manufacturer of affordable manufactured homes, tiny homes, and accessory dwelling units. It mainly caters to low- and middle-income consumers across North America, providing customizable residential solutions, supporting construction materials, and after-sales services for individual and community development clients.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

LEGH vs RCEL — Head-to-Head

Bigger by revenue
LEGH
LEGH
1.4× larger
LEGH
$25.5M
$17.6M
RCEL
Growing faster (revenue YoY)
RCEL
RCEL
+26.3% gap
RCEL
-4.3%
-30.6%
LEGH
Higher net margin
LEGH
LEGH
98.1% more per $
LEGH
32.2%
-66.0%
RCEL
More free cash flow
LEGH
LEGH
$21.8M more FCF
LEGH
$15.7M
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
-9.1%
LEGH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LEGH
LEGH
RCEL
RCEL
Revenue
$25.5M
$17.6M
Net Profit
$8.2M
$-11.6M
Gross Margin
26.4%
81.2%
Operating Margin
40.4%
-59.1%
Net Margin
32.2%
-66.0%
Revenue YoY
-30.6%
-4.3%
Net Profit YoY
-43.5%
-0.3%
EPS (diluted)
$0.38
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LEGH
LEGH
RCEL
RCEL
Q4 25
$25.5M
$17.6M
Q3 25
$28.8M
$17.1M
Q2 25
$38.4M
$18.4M
Q1 25
$24.3M
$18.5M
Q4 24
$36.7M
$18.4M
Q3 24
$30.2M
$19.5M
Q2 24
$31.7M
$15.2M
Q1 24
$30.8M
$11.1M
Net Profit
LEGH
LEGH
RCEL
RCEL
Q4 25
$8.2M
$-11.6M
Q3 25
$8.6M
$-13.2M
Q2 25
$14.7M
$-9.9M
Q1 25
$10.3M
$-13.9M
Q4 24
$14.5M
$-11.6M
Q3 24
$15.8M
$-16.2M
Q2 24
$16.2M
$-15.4M
Q1 24
$15.1M
$-18.7M
Gross Margin
LEGH
LEGH
RCEL
RCEL
Q4 25
26.4%
81.2%
Q3 25
20.2%
81.3%
Q2 25
32.4%
81.2%
Q1 25
29.2%
84.7%
Q4 24
27.3%
87.6%
Q3 24
29.2%
83.7%
Q2 24
31.9%
86.1%
Q1 24
33.6%
86.4%
Operating Margin
LEGH
LEGH
RCEL
RCEL
Q4 25
40.4%
-59.1%
Q3 25
33.7%
-53.6%
Q2 25
43.8%
-60.5%
Q1 25
47.7%
-63.9%
Q4 24
42.3%
-54.1%
Q3 24
50.8%
-70.6%
Q2 24
50.6%
-102.8%
Q1 24
54.3%
-155.0%
Net Margin
LEGH
LEGH
RCEL
RCEL
Q4 25
32.2%
-66.0%
Q3 25
30.0%
-77.3%
Q2 25
38.3%
-53.9%
Q1 25
42.3%
-74.9%
Q4 24
39.5%
-63.0%
Q3 24
52.4%
-82.9%
Q2 24
51.1%
-101.3%
Q1 24
49.1%
-168.0%
EPS (diluted)
LEGH
LEGH
RCEL
RCEL
Q4 25
$0.38
$-0.37
Q3 25
$0.35
$-0.46
Q2 25
$0.60
$-0.38
Q1 25
$0.41
$-0.53
Q4 24
$0.59
$-0.44
Q3 24
$0.64
$-0.62
Q2 24
$0.65
$-0.60
Q1 24
$0.60
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LEGH
LEGH
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$8.5M
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$528.6M
$-16.6M
Total Assets
$580.3M
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LEGH
LEGH
RCEL
RCEL
Q4 25
$8.5M
$18.2M
Q3 25
$13.6M
$23.3M
Q2 25
$2.6M
$15.7M
Q1 25
$3.4M
$25.8M
Q4 24
$1.1M
$35.9M
Q3 24
$570.0K
$44.4M
Q2 24
$60.0K
$54.1M
Q1 24
$621.0K
$68.2M
Stockholders' Equity
LEGH
LEGH
RCEL
RCEL
Q4 25
$528.6M
$-16.6M
Q3 25
$521.6M
$-6.7M
Q2 25
$512.8M
$-12.9M
Q1 25
$503.7M
$-4.6M
Q4 24
$494.0M
$4.5M
Q3 24
$479.3M
$12.2M
Q2 24
$463.2M
$23.9M
Q1 24
$450.4M
$32.6M
Total Assets
LEGH
LEGH
RCEL
RCEL
Q4 25
$580.3M
$56.4M
Q3 25
$557.9M
$63.7M
Q2 25
$552.0M
$58.1M
Q1 25
$544.6M
$69.6M
Q4 24
$534.2M
$79.7M
Q3 24
$521.4M
$81.1M
Q2 24
$514.9M
$87.8M
Q1 24
$510.0M
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LEGH
LEGH
RCEL
RCEL
Operating Cash FlowLast quarter
$19.0M
$-5.4M
Free Cash FlowOCF − Capex
$15.7M
$-6.1M
FCF MarginFCF / Revenue
61.6%
-34.7%
Capex IntensityCapex / Revenue
13.1%
3.8%
Cash ConversionOCF / Net Profit
2.32×
TTM Free Cash FlowTrailing 4 quarters
$28.2M
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LEGH
LEGH
RCEL
RCEL
Q4 25
$19.0M
$-5.4M
Q3 25
$7.2M
$-5.2M
Q2 25
$6.1M
$-10.2M
Q1 25
$4.9M
$-10.3M
Q4 24
$7.9M
$-8.1M
Q3 24
$13.8M
$-7.2M
Q2 24
$3.5M
$-12.8M
Q1 24
$10.8M
$-20.9M
Free Cash Flow
LEGH
LEGH
RCEL
RCEL
Q4 25
$15.7M
$-6.1M
Q3 25
$5.1M
$-6.2M
Q2 25
$3.7M
$-10.8M
Q1 25
$3.6M
$-10.5M
Q4 24
$6.0M
$-9.7M
Q3 24
$9.1M
$-11.0M
Q2 24
$1.7M
$-15.4M
Q1 24
$9.9M
$-22.0M
FCF Margin
LEGH
LEGH
RCEL
RCEL
Q4 25
61.6%
-34.7%
Q3 25
17.8%
-36.1%
Q2 25
9.6%
-58.4%
Q1 25
15.0%
-56.9%
Q4 24
16.4%
-52.7%
Q3 24
30.2%
-56.1%
Q2 24
5.4%
-101.6%
Q1 24
32.2%
-198.2%
Capex Intensity
LEGH
LEGH
RCEL
RCEL
Q4 25
13.1%
3.8%
Q3 25
7.1%
5.5%
Q2 25
6.2%
2.8%
Q1 25
5.2%
1.2%
Q4 24
5.1%
8.8%
Q3 24
15.6%
19.2%
Q2 24
5.5%
17.5%
Q1 24
2.8%
10.3%
Cash Conversion
LEGH
LEGH
RCEL
RCEL
Q4 25
2.32×
Q3 25
0.83×
Q2 25
0.41×
Q1 25
0.48×
Q4 24
0.54×
Q3 24
0.88×
Q2 24
0.21×
Q1 24
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LEGH
LEGH

Commercial Sales$8.6M34%
Retail Store Sales$6.0M24%
Inventory Finance Sales$5.0M20%
Direct Sales$4.4M17%
Other$1.5M6%

RCEL
RCEL

Segment breakdown not available.

Related Comparisons